Biotechnology
Medical
Biopharmaceutical

Alnylam Pharmaceuticals

$74.24
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.45 (1.99%) Today
$0.00 (0.00%) As of 4:06 PM EDT after-hours

Why Robinhood?

You can buy or sell ALNY and other stocks, options, ETFs, and crypto commission-free!

About ALNY

CEO
Employees
1,065
Headquarters
Founded
2002
Market Cap
7.90B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
895.08K
High Today
$74.45
Low Today
$71.90
Open Price
$72.79
Volume
507.71K
52 Week High
$124.22
52 Week Low
$60.27

Collections

Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
Health
Therapy
Technology
US

ALNY News

Wall Street JournalJul 11

New Alnylam Pharmaceuticals CFO Faces Competition Challenge With Pfizer

29
Yahoo FinanceJun 24

Alnylam Presents New ONPATTRO® (patisiran) Results at the 2019 Peripheral Nerve Society Annual Meeting

143
Yahoo FinanceJun 21

Alnylam Announces Progress with RNAi Therapeutics Platform, Including Oral Route of Administration and CNS and Ocular Delivery

17

ALNY Earnings

-$2.28
-$1.92
-$1.56
-$1.20
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, Pre-Market

More ALNY News

Yahoo FinanceJun 19

Here’s What Hedge Funds Think About Alnylam Pharmaceuticals, Inc.

34
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.